Replies to post #180474 on Biotech Values

[DewDiligence]

There should be a law [against tax-inverting companies reimbursing executives for capital-gains taxes consequent to the inversion].

At a minimum, the US tax code ought not to treat such reimbursement payments as tax-deductible compensation.